• 1
    Dubey JP, Lindsay DS, Saville WJA, et al. A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM). Vet Parasitol 2001;95:89131.
  • 2
    Finno CJ, Aleman M, Pusterla N. Equine protozoal myeloencephalitis associated with neosporosis in 3 horses. J Vet Intern Med 2007;21:14051408.
  • 3
    Furr M, MacKay R, Granstrom D, et al. Clinical diagnosis of equine protozoal myeloencephalitis (EPM). J Vet Intern Med 2002;16:618621.
  • 4
    Granstrom DE, Dubey JP, Davis SW, et al. Equine protozoal myeloencephalitis: Antigen analysis of cultured Sarcocystis neurona merozoites. J Vet Diagn Invest 1993;5:8890.
  • 5
    Granstrom DE. Equine protozoal myeloencephalitis: parasite biology, experimental disease, and laboratory diagnosis. In: Proceedings of the International Equine Neurology Conference 1997, p.4.
  • 6
    Bernard WV. Sarcocystis neurona antibodies in equine cerebrospinal fluid. In: Proceedings of the American Association of Equine Practitioners 1998, pp.140–141.
  • 7
    Daft BM, Barr BC, Gardner IA, et al. Sensitivity and specificity of western blot testing of cerebrospinal fluid and serum for diagnosis of equine protozoal myeloencephalitis in horses with and without neurologic abnormalities. J Am Vet Med Assoc 2002;221:10071013.
  • 8
    Duarte PC, Daft BM, Conrad PA, et al. Comparison of a serum indirect fluorescent antibody test with two Western blot tests for the diagnosis of equine protozoal myeloencephalitis. J Vet Diagn Invest 2003;15:813.
  • 9
    Duarte PC, Daft BM, Conrad PA, et al. Evaluation and comparison of an indirect fluorescent antibody test for detection of antibodies to Sarcocystis neurona, using serum and cerebrospinal fluid of naturally and experimentally infected, and vaccinated horses. J Parasitol 2004;90:379386.
  • 10
    Ellison SP, Kennedy T, Brown KK. Development of an ELISA to detect antibodies to rSAG1 in the horse. Int J Appl Res Vet Med 2003;1:318327.
  • 11
    Hoane JS, Morrow JK, Saville WJ, et al. Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens. Clin Diagn Lab Immunol 2005;12:10501056.
  • 12
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:2936.
  • 13
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839843.
  • 14
    Howe DK, Gaji RY, Marsh AE, et al. Strains of Sarcocystis neurona exhibit differences in their surface antigens, including the absence of the major surface antigen SnSAG1. Int J Parasitol 2008;38:623631.
  • 15
    Crowdus CA, Marsh AE, Saville WJ, et al. SnSAG5 is an alternative surface antigen of Sarcocystis neurona strains that is mutually exclusive to SnSAG1. Vet Parasitol 2008;158:3643.
  • 16
    Rossano MG, Kaneene JB, Schott HC, et al. Assessing the agreement of Western blot test results for paired serum and cerebrospinal fluid samples from horses tested for antibodies to Sarcocystis neuronaf. Vet Parasitol 2003;115:233238.
  • 17
    Duarte PC, Ebel ED, Traub-Dargatz J, et al. Indirect fluorescent antibody testing of cerebrospinal fluid for diagnosis of equine protozoal myeloencephalitis. Am J Vet Res 2006;67:869876.
  • 18
    Miller MM, Sweeney CR, Russell GE, et al. Effects of blood contamination of cerebrospinal fluid on western blot analysis for detection of antibodies against Sarcocystis neurona and on albumin quotient and immunoglobulin G index in horses. J Am Vet Med Assoc 1999;215:6771.
  • 19
    Finno CJ, Packham AE, Wilson WD, et al. Effects of blood contamination of cerebrospinal fluid on results of indirect fluorescent antibody tests for detection of antibodies against Sarcocystis neurona and Neospora hughesi. J Vet Diagn Invest 2007;19:286289.
  • 20
    Saville WJA. Comparison of diagnostic tests for EPM run on blinded sera at four different laboratories. EPM Special Interest Group (SIG) at American College of Veterinary Internal Medicine Forum, 1997.